| Patents for C07C 239 - Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof (5,130) |
|---|
| 09/08/2010 | CN101823981A Method for synthesizing N-isopropylhydroxyla |
| 08/19/2010 | WO2010061220A3 Novel processes and pure polymorphs |
| 08/17/2010 | US7777077 Dual-acting antihypertensive agents |
| 08/12/2010 | WO2010061219A3 Polymorphs |
| 08/11/2010 | CN201543424U DEHA reaction kettle |
| 08/05/2010 | US20100197799 Hydroxylamine derivatives |
| 07/29/2010 | WO2010063700A3 Novel pyrazole-4 -n-alkoxycarboxamides as microbiocides |
| 07/28/2010 | CN101788557A Method of purifying/concentrating sugar chain with sugar chain-trapping molecule and method of analyzing sugar chain structure |
| 07/27/2010 | US7763751 such as N-(5-hydroxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-O-methyl-hydroxylamine, useful for the prevention, treatment and diagnosis of nervous system disorders related to protein misfolding and/or misaggregation of beta-amyloid peptide, alpha-synuclein, prion protein and huntingtin gene |
| 06/30/2010 | EP1828258B1 N-substituted imides as polymerization initiators |
| 06/29/2010 | US7745663 mitogen-activated protein kinase inhibitors such as 3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-N-(2-hydroxy-ethoxy)-5(2-hydroxy-ethoxymethyl)-benzamide, used to treat proliferative diseases, for example, cancers, psoriasis, restenosis, autoimmune diseases and atherosclerosis |
| 06/24/2010 | WO2010069266A1 Heterocyclic nitrogenous or oxygenous compounds with insecticidal activity formed from dialdehydes and their preparation and uses thereof |
| 06/10/2010 | WO2010063700A2 Novel microbiocides |
| 06/10/2010 | CA2744509A1 Novel pyrazole-4-n-alkoxycarboxamides as microbiocides |
| 06/09/2010 | CN101724099A Aromatic ketone compound and photoinitiator with same |
| 06/03/2010 | WO2010062333A1 Polymorphs of vorinostat and vorinostat potassium salt and process for preparation thereof |
| 06/03/2010 | WO2010061220A2 Novel processes and pure polymorphs |
| 06/03/2010 | WO2010061219A2 Polymorphs |
| 06/03/2010 | WO2010032147A3 Hydroxamic acid derivatives useful as antibacterial agents |
| 06/03/2010 | CA2744458A1 Novel processes and pure polymorphs |
| 06/03/2010 | CA2744448A1 Polymorphs |
| 06/02/2010 | EP1483228B1 Nk1 antagonists |
| 05/26/2010 | CN101712632A Substituted tetracycline compounds |
| 05/11/2010 | US7714170 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis |
| 05/11/2010 | US7714167 Catalytic asymmetric epoxidation |
| 05/11/2010 | US7713961 Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof |
| 05/06/2010 | US20100113830 Method for producing arylhydroxylamine |
| 05/05/2010 | CN1753864B Method of purifying/concentrating sugar chain with sugar chain-trapping molecule and method of analyzing sugar chain structure |
| 04/27/2010 | CA2345118C Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/27/2010 | CA2338968C Glucocorticoid-selective agents |
| 04/22/2010 | WO2010043953A2 Novel bridged cyclic compounds as histone deacetylase inhibitors |
| 04/20/2010 | US7700658 Administering 3-[[3-(4-chloro-3-ethylphenoxy)phenyl][[3-(1,1,2,2- tetrafluoroethoxy)phenyl]-methyl]amino]- 1,1,1-trifluoro-2-propanol(ylgucpd25); anticholesterol agents to increase the level of high density lipoproteins; atherosclerosis; coronary artery; strokes, cardiovasculardiseases; dyslipidemia |
| 04/13/2010 | US7696377 Stabilizer and method for stabilizing hydroxylamine, and stabilized hydroxylamine solution |
| 03/30/2010 | US7687662 e.g. 1-({[(2,3-difluorobenzoyl)amino]acetyl}amino)-3-methylbutyl]boronic acid; anticarcinogenic, antiproliferative agent |
| 03/25/2010 | WO2010032147A2 Hydroxamic acid derivatives useful as antibacterial agents |
| 03/25/2010 | CA2735929A1 Hydroxamic acid derivatives useful as antibacterial agents |
| 03/24/2010 | CN101679219A Synthetic ion channels |
| 03/18/2010 | US20100068139 Methods of radiofluorination of biologically active vectors |
| 03/03/2010 | CN101663265A Method for producing arylhydroxylamine |
| 02/25/2010 | US20100048953 Process for Preparing 2-Aminooxyethanol |
| 02/17/2010 | EP2154125A1 Method for producing arylhydroxylamine |
| 02/17/2010 | CN101648887A Method for synthesizing o-trans-(3-Cl-2-propenyl) hydroxylamine hydrochloride |
| 02/16/2010 | US7663001 Preparation of isoxazolin-3-ylacylbenzene |
| 02/11/2010 | WO2010017470A1 C7-fluoro substituted tetracycline compounds |
| 02/11/2010 | US20100036153 Method for Producing Substituted Diamantanes |
| 02/11/2010 | CA2732883A1 C7-fluoro substituted tetracycline compounds |
| 02/03/2010 | CN100586485C Methods of radiofluorination of biologically active vectors |
| 02/02/2010 | US7655695 N-hydroxy-N-(methylacylfulvene)urea; solid tumor in a lung, ovarian, prostate, breast, endometrial, bladder, renal, pancreatic, central nervous system, melanoma, colon carcinoma or hematologic cancer; leukemia |
| 01/27/2010 | EP1901994B1 Process for the continuous production of hydroxylammonium |
| 01/06/2010 | CN100577634C Process for the preparation of polyalkoxyamines which can be used as initiators for the radical polymerization of polyfunctional living (co)polymers |
| 12/16/2009 | CN100569740C N-OR amides compound, its preparing method and use |
| 12/15/2009 | US7632866 Meclofenamic acid derivatives, for example; useful in the treatment of conditions such as central or peripheral nervous system disorders through the modulation of potassium ion flux through voltage-dependent potassium channels and/or depressing cortical and/or peripheral neuron activity |
| 12/02/2009 | CN100564352C Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof |
| 11/25/2009 | CN101585782A Method for synthesizing N-methyl-N-methoxy-2-(4-cyclopropoxycarbonylphenyl)-2-methacrylamide |
| 11/17/2009 | US7618914 Method for producing hydroxylamine compound using platinum catalyst fixed on ion-exchange resin |
| 11/11/2009 | EP2114870A1 Synthetic ion channels |
| 11/11/2009 | EP2114864A1 Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof |
| 10/22/2009 | WO2009129097A1 Nitrated hydrocarbons, derivatives, and processes for their manufacture |
| 10/22/2009 | CA2720646A1 Nitrated hydrocarbons, derivatives, and processes for their manufacture |
| 10/20/2009 | CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection |
| 10/14/2009 | CN101558036A Process for preparing 2-aminooxyethanol |
| 10/13/2009 | US7601876 Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis |
| 10/13/2009 | US7601872 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 10/01/2009 | US20090247506 Antibacterial agents |
| 09/30/2009 | EP2104661A1 Process for preparing 2-aminooxyethanol |
| 09/16/2009 | CN101531614A Method for preparing aromatic hydroxylamine through selective hydrogenation of aromatic nitro compound with nano Pt/C catalyst |
| 09/15/2009 | US7589072 carrier having guanidinium groups enhancing drug delivering across a biological membrane, nuclear membrane or blood-brain barrier into a cell; an ionic complex through ionic bonds between the carrier and the drug or diagnostic reagent |
| 09/11/2009 | WO2009065406A3 Novel cyclic hydrocarbon compounds for the treatment of diseases |
| 09/09/2009 | CN101525304A Preparation method for nitrogen-chloro acetanilide containing halogenated functional group |
| 08/25/2009 | US7579411 Process for the controlled increase in the molecular weight of polyethylenes |
| 08/25/2009 | US7579376 N-geranoyltyrosine and N-geranoylcycteine as excellant antitumor and anticarcinogenic agents |
| 08/19/2009 | CN101511778A Chemical process |
| 08/12/2009 | CN101503375A Method for synthesizing methoxy amine hydrochlorate |
| 08/12/2009 | CN101503374A Technique for synthesizing N,N-dimethyl hydroxyl amine |
| 08/04/2009 | US7569724 Antiproliferative agnets; anticancer agents; skin disorders |
| 07/28/2009 | US7566730 Substituted aminoethers for the treatment of Alzheimer's disease |
| 07/23/2009 | WO2009089680A1 Method of modulating membrane potential of a cell |
| 07/07/2009 | US7557143 Such as 3,5-Dibromo-4-(4-hydroxy-3-phenethylcarbamoyl-phenoxy)-phenyl acetic acid; metabolism regulation agents; avoiding cardiovascular and other toxicities of hormones |
| 07/01/2009 | CN100506806C [1.2]-oxazin-3,5-diones |
| 07/01/2009 | CN100506776C NK1 antagonists |
| 06/30/2009 | US7553831 Beta-secretase inhibitors; inhibiting cleavage of amyloid precursor protein (APP); hydroxy-functional disubstituted amines such as 6-(([[(2S,3S)-4-(3,5-difluorophenyl)-3-((3-[(dipropylamino)carbonyl]benzoyl)amino)-2-hydroxybutyl](ethyl)amino]carbonyl)amino)hexanoic acid |
| 06/30/2009 | CA2406088C Novel phenyl-propargylether derivatives |
| 06/25/2009 | US20090163496 Antibacterial agents |
| 06/18/2009 | US20090156685 (r)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity |
| 06/11/2009 | US20090149415 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex |
| 05/28/2009 | WO2009065406A2 Novel cyclic hydrocarbon compounds for the treatment of diseases |
| 05/28/2009 | US20090137845 Novel 4-Dedimethylaminotetracycline derivatives |
| 05/28/2009 | CA2706076A1 Novel cyclic hydrocarbon compounds for the treatment of diseases |
| 05/26/2009 | US7538141 N-benzyl-2-{3-[2-({2-hydroxy-2-[5-hydroxy-6-(hydroxymethyl)pyridin-2-yl]ethyl}amino)-2-methylpropyl]phenyl}acetamide; beta 2 adrenergic receptors agonist; antiinflammatory, antiallergent, respiratory system disorder; side effect reduction; pharmacokinetics, potency, selectivity, duration of action |
| 05/21/2009 | US20090131707 Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds |
| 05/20/2009 | EP2059498A2 Treatment of cancer |
| 05/13/2009 | CN101429136A Process for producing N-benzyl hydroxylamine and hydrochlorate |
| 05/12/2009 | US7531573 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 04/30/2009 | US20090112024 Stabilization of hydroxylamine containing solutions and method for their preparation |
| 04/29/2009 | CN101421228A Preparation of chiral amides and amines |
| 04/28/2009 | US7524989 Using diethylenetriaminepentaacetic acid, triethylenetetraminehexacetic acid, and other organonitrogen compounds |
| 04/16/2009 | WO2003082205A3 Compounds and methods |
| 04/07/2009 | US7514582 Cardiac ANTIARRHYTHMIA AGENTS; atrial fibrillation or atrial flutter; Kv1.5 potassium channel blockers; |
| 04/07/2009 | CA2362833C Phenylalaninol derivatives |
| 03/19/2009 | US20090074746 Compounds to treat alzheimer's disease |